GoodRx Holdings, Inc. Class A (GDRX) Dividend History

Company News

• More Zero-cost Virtual Healthcare Appointments Available to Those Affected by Wildfires in Southern California

  Sesame, a healthcare marketplace, is offering no-cost virtual healthcare appointments to Los Angeles residents affected by wildfires, including primary care, prescription refills, and mental health medication management.

  GlobeNewswire Inc.

  Featured Companies: ABNB TDOC
• Why GoodRx Holdings Stock Was Sinking This Week

  GoodRx's Q3 2023 earnings missed analyst estimates, with revenue and guidance falling short. The company's stock price dropped nearly 19% as a result, despite growth in key metrics like prescription transactions and monthly active consumers. Increased competition, particularly from Amazon's push into same-day pharmaceutical delivery, is seen as a challenge for GoodRx's future performance.

  The Motley Fool

  Featured Companies: AMZN
• RBC holds firm on GoodRx stock target with Outperform rating - Investing.com

  RBC Capital maintained its Outperform rating on GoodRx Holdings Inc. with a steady price target of $10.00. The upcoming quarterly report is anticipated to focus on the growth of Monthly Active Consumers, a key metric for the firm. RBC expects this growth to support GoodRx's guidance of mid-single-digit percentage revenue growth and an EBITDA margin surpassing 30%.

  Investing.com

  Featured Companies: KR
• The Analyst Landscape: 7 Takes On GoodRx Holdings

  Throughout the last three months, 7 analysts have evaluated GoodRx Holdings (NASDAQ:GDRX), offering a diverse set of opinions from bullish to bearish. The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 5 1 0 0 Last 30D 0 0 1 0 0 1M Ago 1 3 0 0 0 2M Ago 0 0 0 0 0 3M Ago 0 2 0 0 0 In the assessment of 12-month price targets, analysts unveil insights for GoodRx Holdings, presenting an average target of $10.64, a high estimate of $16.00, and a low estimate of $9.00. Witnessing a positive shift, the current average has risen by 12.0% from the previous average price target of $9.50. Analyzing Analyst Ratings: A Detailed Breakdown A clear picture of GoodRx Holdings's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Craig Hettenbach Morgan Stanley Raises Equal-Weight $9.50 $7.00 Mark Mahaney RBC Capital Raises Outperform $10.00 $8.00 Stephanie Davis Barclays Raises Overweight $10.00 $9.00 John Ransom Raymond James Announces Outperform $10.00 - Charles Rhyee TD Cowen Raises Buy $16.00 $14.00 Scott Schoenhaus Keybanc Announces Overweight $9.00 - Stan Berenshteyn Wells Fargo Announces Overweight $10.00 - Key Insights: Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects ...Full story available on Benzinga.com

  Benzinga
• GoodRx Strengthens Core Business With New Initiatives, Analyst Upgrades On Potential Opportunities

  RBC Capital Markets issued an upgrade for GoodRx Holdings Inc (NASDAQ:GDRX) shares. The analyst stated the Integrated Savings Program (ISP) and direct contracting (DC) initiatives, along with the expansion of its manufacturing solutions business, offered significant new growth opportunities and strengthened the stability of its core Rx transaction business. Related: Change Healthcare Cyberattack: GoodRx Expects Low Single Digit Million-Dollar Impact In 2024. “We think this ‘hybrid’ approach presents both some incremental revenue opportunity while also better insulating GDRX from PBM-retailer disruptions like what happened with Kroger in mid-2022,” RBC wrote. GoodRx announced a new direct contracting agreement with Kroger Co. (NYSE:KR) earlier this ...Full story available on Benzinga.com

  Benzinga

  Featured Companies: KR